Virtual Library

Start Your Search

  • WCLC 2019

    2019 World Conference on Lung Cancer

    Access to all presentations that occur during the 2019 World Conference on Lung Cancer in Barcelona, Spain

    Presentation Date(s):  
    • Sept 7 - 10, 2019
    • Total Presentations: 2848

    To review abstracts of the presentations below, narrow down your search by using the Filter options below, and then select the session listing of your choice. Click the "+" for a presentation to expand & view the corresponding Abstract details.

    Presentations will be available 24 hours after their live presentation time

Filter Results:

Show Only Available Presentations

  • +

    EP1.03 - Biology

    • Type: E-Poster Viewing in the Exhibit Hall
    • Track: Biology
    • Presentations: 0
    • Coordinates: 9/08/2019, 08:00 - 18:00, Exhibit Hall
    • +

      EP1.03-01 - Molecular Spectrum of Patients with JAK1 Mutations in East Asian Non-Small Cell Lung Cancer

      08:00 - 08:00  |  Author(s): Xiuyi Yu

      • Abstract

      Loading...

    • +

      EP1.03-03 - Association Between Molecular Spectrum of EZH2 Variants and Prognosis in Patients with Non-Small-Cell Lung Cancer in Chinese Patients

      08:00 - 08:00  |  Author(s): Hong Wang

      • Abstract

      Loading...

    • +

      EP1.03-06 - POLD1 Mutations Define a Unique Molecular Class of Non-Small Cell Lung Cancer in Chinese Patients

      08:00 - 08:00  |  Author(s): Wenxian Wang

      • Abstract

      Loading...

    • +

      EP1.03-07 - Prevalence and Clinicopathological Characteristics of EIF1AX Mutations in Chinese Patients with Non-Small Cell Lung Cancer

      08:00 - 08:00  |  Author(s): Wenxian Wang

      • Abstract

      Loading...

    • +

      EP1.03-09 - Epidemiological Study of TSC1 Mutations Among Non-Small Cell Lung Cancer Patients in China

      08:00 - 08:00  |  Author(s): Yong Fang

      • Abstract

      Loading...

    • +

      EP1.03-13 - Molecular Characteristics of East Asian Patients with VHL-Mutated Non-Small-Cell Lung Cancer: A Retrospective Study

      08:00 - 08:00  |  Author(s): Jinluan Li

      • Abstract

      Loading...

    • +

      EP1.03-14 - Clinicopathologic Characteristics and Outcomes of Chinese Patients with Non-Small-Cell Lung Cancer and INPP4B Mutations

      08:00 - 08:00  |  Author(s): Dongyong Yang

      • Abstract

      Loading...

    • +

      EP1.03-17 - Outcomes of Molecular Characteristics in Chinese BAP1-Mutant Non-Small Cell Lung Cancer Patients

      08:00 - 08:00  |  Author(s): Honggang Ke

      • Abstract

      Loading...

    • +

      EP1.03-18 - Analysis of IDH1 Mutation Spectrum from Non-Small-Cell Lung Cancer in East Asian Patients

      08:00 - 08:00  |  Author(s): Liping Wang

      • Abstract

      Loading...

    • +

      EP1.03-19 - The Frequency and Prognosis of MDM2 Mutations in East Asian Non-Small-Cell Lung Cancer Patients

      08:00 - 08:00  |  Author(s): Bing Wan

      • Abstract

      Loading...

    • +

      EP1.03-24 - Clinicopathologic Characteristics and Survival Outcome in Chinese Patients with Non-Small Cell Lung Cancer and HGF Mutations

      08:00 - 08:00  |  Presenter: Chunwei Xu

      • Abstract

      Loading...

    • +

      EP1.03-28 - Frequency and Molecular Characteristics of BRCA1 Mutations in Non-Small Cell Lung Cancer from East Asian Patients

      08:00 - 08:00  |  Author(s): Yixiong Huang

      • Abstract

      Loading...

    • +

      EP1.03-35 - Prevalence, Clinicopathologic Characteristics, and Molecular Associations of IGF1R Mutations in East Asian Patients with NSCLC

      08:00 - 08:00  |  Author(s): Xudong Zhao

      • Abstract

      Loading...

  • +

    EP1.14 - Targeted Therapy

    • Type: E-Poster Viewing in the Exhibit Hall
    • Track: Targeted Therapy
    • Presentations: 0
    • Coordinates: 9/08/2019, 08:00 - 18:00, Exhibit Hall
    • +

      EP1.14-45 - ROS1-ADGRG6: A Novel ROS1 Oncogenic Fusion Variant in Lung Adenocarcinoma and the Response to Crizotinib

      08:00 - 08:00  |  Author(s): Xingliang Li

      • Abstract

      Loading...

    • +

      EP1.14-46 - The KIF5B-RET Fusion as a Novel Mechanism of Acquired EGFR Tyrosine Kinase Inhibitor Resistance in Lung Adenocarcinoma

      08:00 - 08:00  |  Author(s): Youcai Zhu

      • Abstract

      Loading...

    • +

      EP1.14-47 - Lung Adenocarcinoma with Concurrent KRAS Mutation and ALK Rearrangement Responding to Crizotinib

      08:00 - 08:00  |  Author(s): Youcai Zhu

      • Abstract

      Loading...

  • +

    P1.01 - Advanced NSCLC

    • Type: Poster Viewing in the Exhibit Hall
    • Track: Advanced NSCLC
    • Presentations: 1
    • Now Available
    • Coordinates: 9/08/2019, 09:45 - 18:00, Exhibit Hall
    • +

      P1.01-19 - Predictive and Prognostic Values of ctDNA Clearance in Osimertinib Treated Advanced Non-Small Cell Lung Cancer Cohort (Now Available)

      09:45 - 09:45  |  Presenter: Yong Song

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    P1.03 - Biology

    • Type: Poster Viewing in the Exhibit Hall
    • Track: Biology
    • Presentations: 0
    • Coordinates: 9/08/2019, 09:45 - 18:00, Exhibit Hall
    • +

      P1.03-24 - Thoracic Injection of PD-1 Blocking Antibody Improves the Murine Model of Malignant Pleural Effusion

      09:45 - 09:45  |  Author(s): Xin-ying Li

      • Abstract

      Loading...

    • +

      P1.03-35 - Analysis of TET2 Gene Aberrations in East Asian Non-Small-Cell Lung Cancer Patients and Evaluation of Their Prognosis

      09:45 - 09:45  |  Author(s): Yinbin Zhang

      • Abstract

      Loading...

    • +

      P1.03-47 - KEAP1 Mutations in East Asian Patients with NSCLC: An Investigation of Prevalence, Clinicopathologic Characteristics and Prognosis

      09:45 - 09:45  |  Author(s): Zongyang Yu

      • Abstract

      Loading...

  • +

    OA02 - A New Vision of Targets and Strategies

    • Type: Oral Session
    • Track: Targeted Therapy
    • Presentations: 1
    • Now Available
    • Moderators:Frank Griesinger
    • Coordinates: 9/08/2019, 10:30 - 12:00, Seoul (2007)
    • +

      OA02.03 - The Third Generation EGFR Inhibitor (EGFR-TKI) HS-10296 in Advanced NSCLC Patients with Resistance to First Generation EGFR-TKI (Now Available)

      10:50 - 11:00  |  Presenter: Shun Lu

      • Abstract
      • Presentation
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    MA14 - The Adequate MTarget Is Still the Issue

    • Type: Mini Oral Session
    • Track: Advanced NSCLC
    • Presentations: 1
    • Now Available
    • Moderators:Diego Signorelli
    • Coordinates: 9/09/2019, 15:45 - 17:15, Hilton Head (1978)
    • +

      MA14.05 - A Randomized Phase III Trial of Fruquintinib Versus Placebo in Patients with Advanced Non-Small Cell Lung Cancer (FALUCA) (Now Available)

      16:15 - 16:20  |  Presenter: Shun Lu

      • Abstract
      • Presentation
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.